Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,113Revenue $M754Net Margin (%)0.9Altman Z-Score9.0
Enterprise Value $M13,025EPS $-0.0Operating Margin %6.7Piotroski F-Score7
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)1.0Higher ROA y-yY
Price/Book76.410-y EBITDA Growth Rate %--Quick Ratio5.0Cash flow > EarningsY
Price/Sales16.95-y EBITDA Growth Rate %--Current Ratio5.0Lower Leverage y-yY
Price/Free Cash Flow220y-y EBITDA Growth Rate %188ROA % (ttm)0.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)17.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M187ROIC % (ttm)80.0Gross Margin Increase y-yN

Gurus Latest Trades with INCY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INCYVanguard Health Care Fund 2016-03-31 Add1.06%$63.05 - $108.45
($75)
$ 72.09-4%Add 68.76%16,227,748
INCYKen Fisher 2016-03-31 Add$63.05 - $108.45
($75)
$ 72.09-4%Add 0.14%14,839
INCYVanguard Health Care Fund 2015-12-31 Add0.08%$100.21 - $126.46
($111.45)
$ 72.09-35%Add 4.15%9,615,828
INCYJoel Greenblatt 2015-12-31 Sold Out -0.01%$100.21 - $126.46
($111.45)
$ 72.09-35%Sold Out0
INCYGeorge Soros 2015-12-31 Buy 0.01%$100.21 - $126.46
($111.45)
$ 72.09-35%New holding4,200
INCYKen Fisher 2015-12-31 Add$100.21 - $126.46
($111.43)
$ 72.09-35%Add 2.23%14,818
INCYVanguard Health Care Fund 2015-09-30 Reduce-0.04%$95.16 - $131.47
($112.12)
$ 72.09-36%Reduce -1.90%9,233,028
INCYJoel Greenblatt 2015-09-30 Reduce-0.01%$95.16 - $131.47
($112.12)
$ 72.09-36%Reduce -53.09%4,861
INCYKen Fisher 2015-09-30 Add$95.16 - $131.47
($112.12)
$ 72.09-36%Add 5.84%14,495
INCYVanguard Health Care Fund 2015-06-30 Reduce-0.15%$88.46 - $110.15
($103.32)
$ 72.09-30%Reduce -7.50%9,411,543
INCYJoel Greenblatt 2015-06-30 Buy 0.01%$88.46 - $110.15
($103.32)
$ 72.09-30%New holding10,363
INCYKen Fisher 2015-06-30 Reduce$88.46 - $110.15
($103.32)
$ 72.09-30%Reduce -7.90%13,695
INCYMariko Gordon 2014-12-31 Sold Out -0.05%$45.6 - $78.89
($65.73)
$ 72.0910%Sold Out0
INCYKen Fisher 2014-12-31 Add$45.6 - $78.89
($65.29)
$ 72.0910%Add 97.08%14,870
INCYVanguard Health Care Fund 2014-09-30 Add0.07%$45.35 - $56.59
($50.13)
$ 72.0944%Add 6.08%10,174,343
INCYMariko Gordon 2014-09-30 Add$45.35 - $56.59
($50.13)
$ 72.0944%Add 6.55%25,283
INCYKen Fisher 2014-09-30 Reduce$45.35 - $55.78
($50.07)
$ 72.0944%Reduce -38.28%7,545
INCYVanguard Health Care Fund 2014-06-30 Add0.68%$43.1 - $56.39
($50.98)
$ 72.0941%Add 95.66%9,591,143
INCYMariko Gordon 2014-06-30 Reduce-0.19%$43.1 - $56.39
($50.98)
$ 72.0941%Reduce -78.93%23,728
INCYGeorge Soros 2014-06-30 Sold Out -0.01%$43.1 - $56.39
($50.98)
$ 72.0941%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INCY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


INCY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAKER JULIANDirector, 10% Owner 2016-03-17Buy800,000$63.9813.39view
BAKER JULIANDirector, 10% Owner 2016-02-25Buy64,290$70.792.49view
BAKER JULIANDirector, 10% Owner 2016-02-16Buy887,165$69.873.84view
BAKER JULIANDirector, 10% Owner 2016-02-12Buy2,251,427$63.5314.2view
SWAIN PAULA JEVP, Human Resources 2016-01-15Sell13,531$76.96-5.73view
Levy Richard SEVP, Chief Drug Dev Officer 2016-01-06Sell3,937$101.86-28.77view
Siegel Eric H.EVP, General Counsel 2015-12-10Sell1,936$107.96-32.8view
Levy Richard SEVP, Chief Drug Dev Officer 2015-12-07Sell3,937$106.18-31.67view
FRIEDMAN PAUL ADirector 2015-11-18Sell225,000$113.83-36.26view
Siegel Eric H.EVP, General Counsel 2015-11-10Sell2,222$104.86-30.81view

Quarterly/Annual Reports about INCY:

News about INCY:

Articles On GuruFocus.com
Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
Frank Sands Acquires Stake in Netflix Feb 23 2016 
Top Insider Trades of the Past Week Feb 19 2016 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Amazon Among Ken Fisher's Best Performing Stocks Oct 19 2015 
Weekly CFO Sells Highlight: Aramark, Incyte Corp Ltd., Facebook Inc. Jun 09 2014 
Weekly Insider Sells Highlight: ARMK, INCY, ESC, HUN Jun 08 2014 
Weekly Insider Sells Highlight: CPN, INCY, GPK, CODE Feb 23 2014 
Weekly CFO Sells Highlight: Pandora Media Inc, Incyte Corp Ltd, Google Inc, American Airlines Group Feb 24 2014 
Weekly CEO Sells Highlight: ExOne Co, Atmel Corporation, Best Buy and Incyte Corp Ltd. Sep 22 2013 

More From Other Websites
Incyte Corp. breached its 50 day moving average in a Bearish Manner : INCY-US : April 29, 2016 Apr 29 2016
Incyte to Present at Upcoming Investor Conferences Apr 28 2016
Incyte to Present at Upcoming Investor Conferences Apr 28 2016
INCYTE CORP Files SEC form 8-K, Change in Directors or Principal Officers Apr 18 2016
Incyte Investor Event at AACR 2016 to Highlight Innovative and Diversified Research and Development... Apr 15 2016
Incyte Investor Event at AACR 2016 to Highlight Innovative and Diversified Research and Development... Apr 15 2016
Incyte to Report First Quarter Financial Results Apr 14 2016
Incyte to Report First Quarter Financial Results Apr 14 2016
$35M deal: Incyte licenses Lilly drug for potential new use Apr 11 2016
How Has Incyte’s Jakafi Performed in the US? Apr 08 2016
What Are Incyte’s Revenue Streams? Apr 08 2016
Incyte Continues Its Growth Spree in 2015 Apr 07 2016
How Does Incyte’s Valuation Compare to Peers? Apr 07 2016
XBI Large Caps: Incyte Signs Deal with Eli Lilly Apr 07 2016
Incyte Buys Rights to Jakafi for Graft-Versus-Host Disease Apr 07 2016
INCYTE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Apr 06 2016
5 Biotechs With the Most Upside This Earnings Cycle Apr 06 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)